Related Experiment Video
Updated: Aug 30, 2026

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Stabilization of a Membrane-Associated Amyloid-β Oligomer for Its Validation in Alzheimer's Disease
Montserrat Serra-Batiste1, James Tolchard1,2, Fabrice Giusti3
1Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute Science and Technology (BIST), Barcelona, Spain.
Abstract:
We have recently reported on the preparation of a membrane-associated β-barrel Pore-Forming Aβ42 Oligomer (βPFO). It corresponds to a stable and homogeneous Aβ42 oligomer that inserts into lipid bilayers as a well-defined pore and adopts a specific structure with characteristics of a β-barrel arrangement. As a follow-up of this work, we aim to establish βPFO's relevance in Alzheimer's disease (AD). However, βPFO is formed under dodecyl phosphocholine (DPC) micelle conditions-intended to mimic the hydrophobic environment of membranes-which are dynamic. Consequently, dilution of the βPFO/DPC complex in a detergent-free buffer leads to dispersion of the DPC molecules from the oligomer surface, leaving the oligomer without the hydrophobic micelle belt that stabilizes it. Since dilution is required for any biological test, transfer of βPFO from DPC micelles into another hydrophobic biomimetic membrane environment, that remains associated with βPFO even under high dilution conditions, is a requisite for the validation of βPFO in AD. Here we describe conditions for exchanging DPC micelles with amphipols (APols), which are amphipathic polymers designed to stabilize membrane proteins in aqueous solutions. APols bind in an irreversible but non-covalent manner to the hydrophobic surface of membrane proteins preserving their structure even under extreme dilution conditions. We tested three types of APols with distinct physical-chemical properties and found that the βPFO/DPC complex can only be trapped in non-ionic APols (NAPols). The characterization of the resulting βPFO/NAPol complex by biochemical tools and structural biology techniques allowed us to establish that the oligomer structure is maintained even under high dilution. Based on these findings, this work constitutes a first step towards the in vivo validation of βPFO in AD.
Insights
Researchers stabilized a pore-forming amyloid-beta oligomer (βPFO) using amphipols, enabling its study in Alzheimer's disease research. This method maintains the oligomer's structure under dilution, crucial for further biological validation.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- A beta-sheet pore-forming amyloid-beta 42 oligomer (βPFO) has been prepared, exhibiting a stable β-barrel structure.
- βPFO's relevance to Alzheimer's disease (AD) requires its stabilization in aqueous solutions for biological testing.
- Current stabilization in dodecyl phosphocholine (DPC) micelles is lost upon dilution, hindering further research.
Purpose of the Study:
- To develop a method for transferring βPFO from DPC micelles to a stable, biomimetic membrane environment.
- To validate the structural integrity of βPFO when stabilized by alternative agents under dilution conditions.
- To enable future in vivo studies of βPFO's role in Alzheimer's disease pathogenesis.
Main Methods:
- Exchange of DPC micelles with amphipols (APols), amphipathic polymers designed for membrane protein stabilization.
- Testing of three distinct APol types to identify optimal stabilization conditions for the βPFO/DPC complex.
- Characterization of the resulting βPFO/APol complex using biochemical and structural biology techniques.
Main Results:
- Non-ionic APols (NAPols) were found to effectively trap the βPFO/DPC complex.
- The βPFO oligomer structure was maintained in the βPFO/NAPol complex even under high dilution.
- Structural integrity was confirmed through biochemical assays and advanced structural biology methods.
Conclusions:
- Successful transfer and stabilization of βPFO from DPC micelles to NAPols has been achieved.
- This stabilization method preserves the oligomer's structure under dilution, overcoming a major limitation.
- This work represents a critical first step towards the in vivo validation of βPFO in Alzheimer's disease.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology

